GMP CELL BANKING SERVICES MARKET ANALYSIS

Market News

Global GMP Cell Banking Services Market: Key Developments

In September 2022, FUJIFILM Diosynth Biotechnologies, a world-leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, announced the expansion of its large-scale microbial manufacturing facility located at the Billingham, U.K. campus

In April 2022, SGS, a U.S.-based contract manufacturing organization, announced a partnership with Liveome, a Korea-based drug developer, for the formulation, development, and clinical manufacture of a targeted release formulation containing lyophilized microbial cells and to build a cell bank, for the development and production process of drug

In April 2022, FUJIFILM Corporation, a contract development and manufacturing organization (CDMO), announced that it has completed the acquisition of Atara Biotherapeutics, Inc., a dedicated cell therapy manufacturing company, to produce both clinical and commercial cell therapies including allogeneic T-cell and CAR T immunotherapies

Global GMP Cell Banking Services Market: Key Trends

Increasing inorganic growth strategies such as partnership by key players in the market

Increasing inorganic growth strategies such as partnership by key players in the market to expand their product portfolio is expected to drive market growth over the forecast period. For instance, in January 2021, Sartorius AG, a life science company, announced a partnership with RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cell (hMSC) working cell banks to advance cell and gene therapy manufacturing and also scale-up of hMSC manufacturing for regenerative medicine